Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Placenta ; 32(11): 877-84, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21937108

RESUMO

PLAC1 expression, first characterized as restricted to developing placenta among normal tissues, is also found in a wide range of tumors and transformed cell lines. To understand the basis for its unusual expression profile, we have analyzed the gene structure and its mode of transcription. We find that the gene has a hitherto unique feature, with two promoters, P1 and P2, separated by 105 kb. P2 has been described before. Here we define P1 and show that it and P2 are activated by RXRα in conjunction with LXRα or LXRß. In placenta, P2 is the preferred promoter, whereas various tumor cell lines tend to express predominantly either one or the other promoter. Furthermore, when each promoter is fused to a luciferase reporter gene and transfected into cancer cell lines, the promoter corresponding to the more active endogenous promoter is preferentially transcribed. Joint expression of activating nuclear receptors can partially account for the restricted expression of PLAC1 in placenta, and may be co-opted for preferential P1 or P2 PLAC1 expression in various tumor cells.


Assuntos
Neoplasias/genética , Receptores Nucleares Órfãos/fisiologia , Placenta/metabolismo , Proteínas da Gravidez/genética , Regiões Promotoras Genéticas , Receptor X Retinoide alfa/fisiologia , Ativação Transcricional , Animais , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Receptores X do Fígado , Camundongos , Neoplasias/metabolismo , Especificidade de Órgãos/genética , Receptores Nucleares Órfãos/metabolismo , Gravidez , Proteínas da Gravidez/metabolismo , Receptor X Retinoide alfa/metabolismo , Ativação Transcricional/genética , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...